Synovus Financial Corp Artivion, Inc. Transaction History

Synovus Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$16.35 - $21.4 $106,422 - $139,292	-6,509 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$25.76 - $34.03 $33,488 - $44,239	1,300 Added 24.96%	6,509 $185,000
Q2 2018 Aug 01, 2018	SELL	$19.4 - $29.35 $97,000 - $146,750	-5,000 Reduced 48.98%	5,209 $145,000
Q4 2017 Feb 09, 2018	SELL	$18.65 - $23.85 $895 - $1,144	-48 Reduced 0.47%	10,209 $195,000
Q3 2017 Nov 13, 2017	BUY	$18.85 - $23.05 $193,344 - $236,423	10,257	10,257 $233,000

176

37.1M

29.9K

2.3K

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $972M
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.